Page last updated: 2024-08-22

platinum and pf-06463922

platinum has been researched along with pf-06463922 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Baglivo, S; Bellezza, G; Bonaiti, A; Colafigli, C; Di Girolamo, B; Ludovini, V; Mandarano, M; Matocci, R; Metelli, N; Metro, G; Roila, F1

Other Studies

1 other study(ies) available for platinum and pf-06463922

ArticleYear
Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases.
    Journal of chemotherapy (Florence, Italy), 2023, Volume: 35, Issue:6

    Topics: Anaplastic Lymphoma Kinase; Carcinoma, Non-Small-Cell Lung; Humans; Lactams, Macrocyclic; Lung Neoplasms; Pemetrexed; Platinum; Protein Kinase Inhibitors

2023